Sterility assessment of multiple use botulinum A exotoxin vials: A prospective simulation

被引:24
|
作者
Alam, Murad
Yoo, Simon S.
Wrone, David A.
White, Lucile E.
Kim, John Y. S.
机构
[1] Northwestern Univ, Dept Dermatol, Sect Cutaneous & Aesthet Surg, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Otolaryngol, Chicago, IL 60611 USA
[3] Northwestern Univ, Div Plast Surg, Chicago, IL 60611 USA
关键词
D O I
10.1016/j.jaad.2006.01.019
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background. A preponderance of evidence now indicates that storage of reconstituted botulinum. toxin solution for longer than the 4 hours recommended by the manufacturer does not result in loss of effectiveness. Objective. Then purpose of this study was to assess whether serial re-extraction of reconstituted botulinum toxin solution from vials undergoing prolonged storage is associated with increased risk of microbial contamination. Methods: Consecutive 100-U vials of botulinn A exotoxin were reconstituted with 2.5 mL each of normal saline with preservative (benzyl alcohol). Within 1 week after reconstitution, each vial was used to treat 1 to 3 patients, for a total of 60 to 80 U used. Thereafter, each vial was stored in a plastic kidney basin in an unlocked, multiuse medication refrigerator. Two weeks later, a randomly assigned nurse removed the vial from the refrigerator and withdrew and discarded 0.1 mL, (5 U) using the same technique used for therapeutic extractions. Iterations of this withdrawal and discarding procedure were continued until a 0.1-mL aliquot could not be withdrawn without prying off the metal cover. Once this threshold was reached, the vial was sent to the microbiology laboratory for sterility testing using a thioglycolate broth. Results: In all, 127 vials were handled per protocol. On average (mean), vials underwent 4.5 access procedures, including 1.6 therapeutic extractions for a total of 76 U removed during a period of 7 weeks. Sterility analysis with thioglycolate broth indicated no evidence of contamination. Limitations: Preservative-containing saline was used for reconstitution. Conclusion: Routine refrigerator storage of medication vials containing reconstituted botulinum toxin does not result in microbial contamination of the contents even after serial re-extraction of solution from these vials, and after handling of such vials by multiple personnel. Storage and subsequent reuse of botulinum toxin appears safe for at least 7 weeks after reconstitution.
引用
收藏
页码:272 / 275
页数:4
相关论文
共 50 条
  • [41] Hull prospective analysis of Botulinum Toxin type A (Botox) use in the treatment of chronic migraine
    Ahmed, F.
    Khalil, M.
    Quarshie, V.
    JOURNAL OF HEADACHE AND PAIN, 2013, 14
  • [42] Use of botulinum toxin type A to improve treatment of facial wounds: A prospective randomised study
    Ziade, Makram
    Domergue, Sophie
    Batifol, Dominique
    Jreige, Riad
    Sebbane, Mustapha
    Goudot, Patrick
    Yachouh, Jacques
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2013, 66 (02): : 209 - 214
  • [43] Hull prospective analysis of Botulinum Toxin type A (Botox) use in the treatment of chronic migraine
    F Ahmed
    M Khalil
    V Quarshie
    The Journal of Headache and Pain, 2013, 14
  • [44] Hull Prospective Analysis of Botulinum Toxin Type A (Botox) Use in the Treatment of Chronic Migraine
    Khalil, M.
    Quarshie, V.
    Ahmed, F.
    CEPHALALGIA, 2013, 33 (S8) : 254 - 255
  • [45] Systematic review on the use of botulinum toxin for the detrusor muscle dysfunction in multiple sclerosis
    Nogueira, Eduardo
    Carvalho, Vitor
    Fragoso, Yara
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 141 - 142
  • [46] A prospective study of the use of botulinum toxin injections in the treatment of Raynaud's syndrome associated with scleroderma
    Uppal, L.
    Dhaliwal, K.
    Butler, P. E.
    JOURNAL OF HAND SURGERY-EUROPEAN VOLUME, 2014, 39 (08) : 876 - 880
  • [47] Simulation studies: a new method of prospective technology assessment and design
    C. Kumbruck
    M. J. Schneider
    Quality of Life Research, 1999, 8 : 161 - 170
  • [48] Simulation studies: a new method of prospective technology assessment and design
    Kumbruck, C
    Schneider, MJ
    QUALITY OF LIFE RESEARCH, 1999, 8 (1-2) : 161 - 170
  • [49] The use of simulation for emergency medicine resident assessment
    Bond, MF
    Spillane, L
    ACADEMIC EMERGENCY MEDICINE, 2002, 9 (11) : 1295 - 1299
  • [50] The use of simulation modeling for intermodal capacity assessment
    Kulick, BC
    Sawyer, JT
    PROCEEDINGS OF THE 2000 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, 2000, : 1164 - 1167